Found 184 matching trials
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma PHASE2 Background:
The disease follicular lymphoma (FL) develops when the body ma...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL PHASE1 The aim of this study is to determine the maximal tolerated dose level of l...
Show More Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Learn More & Join Trial
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma PHASE2 RATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune s...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) PHASE2 This open-label, international, multicenter study will investigate the safe...
Show More Location
Southern Cancer Center, PC
Learn More & Join Trial
The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP) PHASE2 TTP is a rare and serious blood disorder, characterized by the formation of...
Show More Location
St Bartholomew's Hospital
Learn More & Join Trial
Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse PHASE1 The purpose of this study is to determine the recommended dose of CMC544 ad...
Show More Learn More & Join Trial
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. PHASE2 Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Show More Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Learn More & Join Trial
Ma-Spore ALL 2020 Study PHASE2 The primary objective of this trial is to improve the overall survival rate...
Show More Location
Subang Jaya Medical Centre
Learn More & Join Trial
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia PHASE3 RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Show More Location
Universitaetsklinik fuer Innere Medizin I
Learn More & Join Trial
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial